サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1672094

フュージョン生検の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）

Global Fusion Biopsy Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日
ページ情報
英文 242 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
フュージョン生検の世界市場調査レポート：産業分析、規模、シェア、成長、動向、予測（2025年～2033年）
出版日: 2025年03月01日
発行: Value Market Research
ページ情報: 英文 242 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

フュージョン生検の世界市場規模は、2024年の13億4,000万米ドルから2033年には27億5,000万米ドルに成長し、2026年から2033年の予測期間中に8.3％の堅調な年間平均成長率（CAGR）を示すと予測されます。

フュージョン生検市場は、イメージング技術の進歩や前立腺がんの有病率の上昇に牽引され、大きな成長を遂げています。フュージョン生検は、従来の超音波画像診断と磁気共鳴画像診断（MRI）を組み合わせて前立腺がんの診断精度を高めるものです。この革新的なアプローチにより、疑わしい病変の標的サンプリングが可能になり、臨床的に重要ながんの検出率が向上する一方、不必要な生検を最小限に抑えることができます。前立腺がんに対する認識が高まり、検診ガイドラインが進化するにつれて、フュージョン生検の需要は増加すると予想され、この市場は堅調な拡大が見込まれます。

さらに、個別化医療を重視する傾向が強まっていることも、フュージョン生検の動向に影響を与えています。腫瘍の特徴に関するより正確な情報を提供することで、ヘルスケア提供者は個々の患者に合わせた治療計画を立てることができます。この標的治療へのシフトは、腫瘍の特異的な生物学的特性を理解することで治療成績に大きな影響を与える腫瘍学において特に重要です。ヘルスケアシステムが精密医療アプローチをますます採用するようになるにつれて、フュージョン生検市場は、患者ケアを強化し資源利用を最適化する高度な診断ツールの統合から恩恵を受ける可能性が高いです。

さらに、低侵襲手術の増加がフュージョン生検技術の採用を促進しています。患者は不快感や回復時間を軽減する選択肢をますます求めるようになっており、フュージョン生検が従来の生検法に代わる魅力的な選択肢となっています。使いやすい装置の開発とヘルスケア専門家向けのトレーニングプログラムが、この技術の採用をさらに促進しています。フュージョン生検市場が進化を続ける中、継続的な調査と技術革新は、その応用範囲の拡大と診断精度の向上に重要な役割を果たし、最終的には前立腺がんとの闘いにおける患者の予後改善に貢献します。

当社のレポートは、様々な産業や市場に関する包括的かつ実用的な洞察をお客様に提供するために、細心の注意を払って作成されています。各レポートには、市場情勢を完全に理解するためのいくつかの重要な要素が含まれています：

市場概要：市場概要：定義、分類、業界の現状など、市場に関する詳細なイントロダクション。

市場促進要因：市場成長に影響を与える主な促進要因・抑制要因・市場促進要因・課題を詳細に分析します。このセクションでは、技術の進歩、規制の変更、新たな動向などの要因を検証します。

セグメンテーション分析：製品タイプ、用途、エンドユーザー、地域などの基準に基づき、市場を明確なセグメントに内訳。この分析により、各セグメントの業績と将来性を明らかにします。

競合情勢：市場シェア、製品ポートフォリオ、戦略的イニシアティブ、財務実績など、主要市場企業の包括的評価。主要企業が採用する競合力学と主要戦略に関する考察を提供します。

市場予測：過去のデータと現在の市場状況に基づき、一定期間における市場規模と成長動向を予測します。これには、定量的分析と将来の市場軌跡を示すグラフ表示が含まれます。

地域分析：地域ごとの市場パフォーマンスを評価し、主要市場や地域動向を明らかにします。地域の市場力学とビジネスチャンスを理解するのに役立ちます。

新たな動向と機会：現在の市場動向と新たな市場動向、技術革新、潜在的な投資対象分野を特定します。将来の市場開拓と成長見通しに関する洞察を提供します。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 フュージョン生検産業分析

  • イントロダクション-市場力学
  • 市場促進要因
  • 市場抑制要因
  • 機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場の魅力分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 フュージョン生検の世界市場分析：技術ターゲット別

  • 技術ターゲット別の概要
  • 技術ターゲット別の実績・予測データ分析
  • DNA
  • RNA
  • タンパク質

第6章 フュージョン生検の世界市場分析：製品別

  • 製品別の概要
  • 製品別の実績・予測データ分析
  • マルチ遺伝子パネル
  • 単一遺伝子検査
  • コンパニオン診断薬
  • 調査専用（RUO）キット

第7章 フュージョン生検の世界市場分析：用途別

  • 用途別の概要
  • 用途別の実績・予測データ分析
  • 腫瘍学
  • 神経学
  • 感染症
  • 心血管疾患

第8章 フュージョン生検の世界市場分析：技術別

  • 技術別の概要
  • 技術別の実績・予測データ分析
  • 次世代シーケンサー（NGS）
  • ポリメラーゼ連鎖反応（PCR）
  • デジタルPCR
  • ナノストリングテクノロジー

第9章 フュージョン生検の世界市場分析：地域別

  • 地域別の展望
  • イントロダクション
  • 北米の売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州の売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他欧州
  • アジア太平洋の売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他アジア太平洋
  • ラテンアメリカの売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他ラテンアメリカ
  • 中東・アフリカの売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東・アフリカ

第10章 フュージョン生検企業の競合情勢

  • フュージョン生検市場競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品発売
  • その他の開発

第11章 企業プロファイル

  • 上位企業の市場シェア分析
  • 市場集中度
  • Hologic Inc.
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • BioRad Laboratories Inc.
  • Invivoscribe
  • Leica Biosystems
  • Affymetrix Inc.
  • Qiagen N.V.
  • BD（Becton, Dickinson and Company）
  • Agilent Technologies Inc.
  • Genomic Health
  • Sysmex Corporation
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina Inc
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Tech Target (0 and USD MN)
  • DNA Market Sales By Geography (0 and USD MN)
  • RNA Market Sales By Geography (0 and USD MN)
  • Protein Market Sales By Geography (0 and USD MN)
  • Analysis By Product (0 and USD MN)
  • Multi-gene Panels Market Sales By Geography (0 and USD MN)
  • Single-gene Tests Market Sales By Geography (0 and USD MN)
  • Companion Diagnostics Market Sales By Geography (0 and USD MN)
  • Research Use Only (RUO) Kits Market Sales By Geography (0 and USD MN)
  • Analysis By Application (0 and USD MN)
  • Oncology Market Sales By Geography (0 and USD MN)
  • Neurology Market Sales By Geography (0 and USD MN)
  • Infectious Diseases Market Sales By Geography (0 and USD MN)
  • Cardiovascular Diseases Market Sales By Geography (0 and USD MN)
  • Analysis By Technology (0 and USD MN)
  • Next-Generation Sequencing (NGS) Market Sales By Geography (0 and USD MN)
  • Polymerase Chain Reaction (PCR) Market Sales By Geography (0 and USD MN)
  • Digital PCR Market Sales By Geography (0 and USD MN)
  • NanoString Technologies Market Sales By Geography (0 and USD MN)
  • Global Fusion Biopsy Market Sales By Geography (0 and USD MN)
  • North America Market Analysis (0 and USD MN)
  • United States Market Analysis (0 and USD MN)
  • Canada Market Analysis (0 and USD MN)
  • Mexico Market Analysis (0 and USD MN)
  • Europe Market Analysis (0 and USD MN)
  • Europe Market Estimate By Country (0 and USD MN)
  • United Kingdom Market Analysis (0 and USD MN)
  • France Market Analysis (0 and USD MN)
  • Germany Market Analysis (0 and USD MN)
  • Italy Market Analysis (0 and USD MN)
  • Russia Market Analysis (0 and USD MN)
  • Spain Market Analysis (0 and USD MN)
  • Rest of Europe Market Analysis (0 and USD MN)
  • Asia Pacific Market Analysis (0 and USD MN)
  • China Market Analysis (0 and USD MN)
  • Japan Market Analysis (0 and USD MN)
  • India Market Analysis (0 and USD MN)
  • South Korea Market Analysis (0 and USD MN)
  • Australia Market Analysis (0 and USD MN)
  • South East Asia Market Analysis (0 and USD MN)
  • Rest of Asia Pacific Market Analysis (0 and USD MN)
  • Latin America Market Analysis (0 and USD MN)
  • Brazil Market Analysis (0 and USD MN)
  • Argentina Market Analysis (0 and USD MN)
  • Peru Market Analysis (0 and USD MN)
  • Chile Market Analysis (0 and USD MN)
  • Rest of Latin America Market Analysis (0 and USD MN)
  • Middle East & Africa Market Analysis (0 and USD MN)
  • Saudi Arabia Market Analysis (0 and USD MN)
  • UAE Market Analysis (0 and USD MN)
  • Israel Market Analysis (0 and USD MN)
  • South Africa Market Analysis (0 and USD MN)
  • Rest of Middle East and Africa Market Analysis (0 and USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Fusion Biopsy Report
  • Market Research Process
  • Market Research Methodology
  • Global Fusion Biopsy Market Size, By Region (0 and USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Tech Target
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By Technology
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Tech Target (0 and USD MN)
  • DNA Market Sales By Geography (0 and USD MN)
  • RNA Market Sales By Geography (0 and USD MN)
  • Protein Market Sales By Geography (0 and USD MN)
  • Global Market Analysis By Product (0 and USD MN)
  • Multi-gene Panels Market Sales By Geography (0 and USD MN)
  • Single-gene Tests Market Sales By Geography (0 and USD MN)
  • Companion Diagnostics Market Sales By Geography (0 and USD MN)
  • Research Use Only (RUO) Kits Market Sales By Geography (0 and USD MN)
  • Global Market Analysis By Application (0 and USD MN)
  • Oncology Market Sales By Geography (0 and USD MN)
  • Neurology Market Sales By Geography (0 and USD MN)
  • Infectious Diseases Market Sales By Geography (0 and USD MN)
  • Cardiovascular Diseases Market Sales By Geography (0 and USD MN)
  • Global Market Analysis By Technology (0 and USD MN)
  • Next-Generation Sequencing (NGS) Market Sales By Geography (0 and USD MN)
  • Polymerase Chain Reaction (PCR) Market Sales By Geography (0 and USD MN)
  • Digital PCR Market Sales By Geography (0 and USD MN)
  • NanoString Technologies Market Sales By Geography (0 and USD MN)
  • Global Market Sales (0 and USD MN)
  • North America Market Sales (0 and USD MN)
  • Europe Market Sales (0 and USD MN)
  • Asia Pacific Market Sales (0 and USD MN)
  • Latin America Market Sales (0 and USD MN)
  • Middle East & Africa Market Sales (0 and USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.
目次
Product Code: VMR11216669

Global Fusion Biopsy Market size is anticipated to grow from USD 1.34 Billion in 2024 to USD 2.75 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 8.3% during the forecast period of 2026 to 2033.

The fusion biopsy market is experiencing significant growth, driven by advancements in imaging technologies and the increasing prevalence of prostate cancer. Fusion biopsy combines traditional ultrasound imaging with magnetic resonance imaging (MRI) to enhance the accuracy of prostate cancer diagnosis. This innovative approach allows for targeted sampling of suspicious lesions, improving the detection rate of clinically significant cancers while minimizing unnecessary biopsies. As awareness of prostate cancer rises and screening guidelines evolve, the demand for fusion biopsy procedures is expected to increase, positioning this market for robust expansion.

Moreover, the growing emphasis on personalized medicine is influencing the fusion biopsy landscape. By providing more precise information about tumor characteristics, fusion biopsy enables healthcare providers to tailor treatment plans to individual patients. This shift towards targeted therapies is particularly relevant in oncology, where understanding the specific biology of a tumor can significantly impact treatment outcomes. As healthcare systems increasingly adopt precision medicine approaches, the fusion biopsy market is likely to benefit from the integration of advanced diagnostic tools that enhance patient care and optimize resource utilization.

Additionally, the rise of minimally invasive procedures is driving the adoption of fusion biopsy techniques. Patients are increasingly seeking options that reduce discomfort and recovery time, making fusion biopsy an attractive alternative to traditional biopsy methods. The development of user-friendly devices and training programs for healthcare professionals is further facilitating the adoption of this technology. As the fusion biopsy market continues to evolve, ongoing research and innovation will play a crucial role in expanding its applications and improving diagnostic accuracy, ultimately contributing to better patient outcomes in the fight against prostate cancer.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Tech Target

  • DNA
  • RNA
  • Protein

By Product

  • Multi-gene Panels
  • Single-gene Tests
  • Companion Diagnostics
  • Research Use Only (RUO) Kits

By Application

  • Oncology
  • Neurology
  • Infectious Diseases
  • Cardiovascular Diseases

By Technology

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Digital PCR
  • NanoString Technologies
  • COMPANIES PROFILED
  • Hologic Inc.
  • Exact Sciences Corporation
  • Myriad Genetics Inc.
  • BioRad Laboratories Inc.
  • Invivoscribe
  • Leica Biosystems
  • Affymetrix Inc.
  • QIAGEN N.V.
  • BD (Becton
  • Dickinson and Company)
  • Agilent Technologies Inc.
  • Genomic Health
  • Sysmex Corporation
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. FUSION BIOPSY INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Tech Target
    • 3.7.2 Market Attractiveness Analysis By Product
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By Technology
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY TECH TARGET

  • 5.1. Overview By Tech Target
  • 5.2. Historical and Forecast Data Analysis By Tech Target
  • 5.3. DNA Historic and Forecast Sales By Regions
  • 5.4. RNA Historic and Forecast Sales By Regions
  • 5.5. Protein Historic and Forecast Sales By Regions

6. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY PRODUCT

  • 6.1. Overview By Product
  • 6.2. Historical and Forecast Data Analysis By Product
  • 6.3. Multi-gene Panels Historic and Forecast Sales By Regions
  • 6.4. Single-gene Tests Historic and Forecast Sales By Regions
  • 6.5. Companion Diagnostics Historic and Forecast Sales By Regions
  • 6.6. Research Use Only (RUO) Kits Historic and Forecast Sales By Regions

7. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Oncology Historic and Forecast Sales By Regions
  • 7.4. Neurology Historic and Forecast Sales By Regions
  • 7.5. Infectious Diseases Historic and Forecast Sales By Regions
  • 7.6. Cardiovascular Diseases Historic and Forecast Sales By Regions

8. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY TECHNOLOGY

  • 8.1. Overview By Technology
  • 8.2. Historical and Forecast Data Analysis By Technology
  • 8.3. Next-Generation Sequencing (NGS) Historic and Forecast Sales By Regions
  • 8.4. Polymerase Chain Reaction (PCR) Historic and Forecast Sales By Regions
  • 8.5. Digital PCR Historic and Forecast Sales By Regions
  • 8.6. NanoString Technologies Historic and Forecast Sales By Regions

9. GLOBAL FUSION BIOPSY MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE FUSION BIOPSY COMPANIES

  • 10.1. Fusion Biopsy Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF FUSION BIOPSY INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Hologic Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Exact Sciences Corporation
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Myriad Genetics Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. BioRad Laboratories Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Invivoscribe
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Leica Biosystems
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Affymetrix Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Qiagen N.V.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. BD (Becton
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Dickinson And Company)
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. Agilent Technologies Inc.
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Genomic Health
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments
  • 11.15. Sysmex Corporation
    • 11.15.1 Company Overview
    • 11.15.2 Company Revenue
    • 11.15.3 Products
    • 11.15.4 Recent Developments
  • 11.16. Beckman Coulter Inc.
    • 11.16.1 Company Overview
    • 11.16.2 Company Revenue
    • 11.16.3 Products
    • 11.16.4 Recent Developments
  • 11.17. Thermo Fisher Scientific Inc.
    • 11.17.1 Company Overview
    • 11.17.2 Company Revenue
    • 11.17.3 Products
    • 11.17.4 Recent Developments
  • 11.18. Illumina Inc
    • 11.18.1 Company Overview
    • 11.18.2 Company Revenue
    • 11.18.3 Products
    • 11.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies